Otros idiomas Jeil Pharma Holdings Inc

Acciones

A002620

KR7002620003

Precio de cierre Korea S.E. Otros sitios de cotización 00:00:00 16/05/2024			Varia. Cinco días.	Varia. 1 de enero.
10.850 ^KRW	+1,69 %		-3,98 %	-7,82 %

2023	Jeil Pharma Holdings Inc presenta los resultados del primer trimestre finalizado el 31 de marzo de 2023	CI
2022	El plan de recompra de acciones de Jeil Pharma Holdings Inc se extiende hasta el 2 de octubre de 2042.	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023	12/05/23
Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042.	28/09/22
Jeil Pharma Holdings Inc completed the acquisition of additional 35.2% stake in Jeil Pharmaceutical Co.,Ltd for approximately KRW 250 billion.	16/11/18
Jeil Pharma Holdings Inc made an offer to acquire an additional 47.6% stake in Jeil Pharmaceutical Co.,Ltd for approximately KRW 490 billion.	02/10/18
Jeil Pharma Holdings Inc(KOSE:A002620) dropped from S&P Global BMI Index	24/09/18
Jeil Pharma Holdings Inc acquired 13.53% stake in Jeil Pharmaceutical Co.,Ltd.	02/05/18
Jeil Pharma Holdings Inc(KOSE:A002620) dropped from KOSPI 200 Index	15/09/17
Jeil Pharma Holdings Inc's Equity Buyback announced on August 28, 2015, has expired.	25/08/17
Jeil Pharma Holdings Inc's Equity Buyback announced on November 7, 2013, has expired.	25/08/17
Jeil Pharmaceutical Co., Ltd. announced the spin-off of its pharmaceuticals manufacturing and sales business.	16/01/17
Jeil Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till November 5, 2017.	04/11/16
Jeil Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till August 26, 2017.	26/08/16
Jeil Pharmaceutical Co., Ltd.(KOSE:A002620) added to KOSPI 200 Index	10/06/16
Tranche Update on Jeil Pharma Holdings Inc's Equity Buyback Plan announced on August 28, 2015.	27/11/15
Jeil Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till November 5, 2016.	06/11/15
Jeil Pharma Holdings Inc announces an Equity Buyback for KRW 2,000 million worth of its shares.	28/08/15
Jeil Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	28/08/15
Jeil Pharmaceutical Co., Ltd's Equity Buyback Plan Extended till November 7, 2013.	07/11/14
Fidelity Management & Research Company and three related parties acquired 11.58% stake in Jeil Pharmaceutical Co., Ltd..	16/05/14
Tranche Update on Jeil Pharma Holdings Inc's Equity Buyback Plan announced on November 7, 2013.	10/02/14

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Jeil Pharma Holdings Inc

Acciones

A002620

KR7002620003

Otros idiomas

Filtros